Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 316,889 | 444,091 | 281,594 | 202,129 | 402,710 |
| Depreciation Amortization | 92,261 | 77,744 | 85,841 | 58,586 | 8,896 |
| Income taxes - deferred | 634 | 532 | 34,506 | 40,005 | -155,434 |
| Accounts receivable | -128,063 | -74,245 | -3,339 | -83,941 | 6,755 |
| Other Working Capital | -152,256 | -89,277 | -38,671 | -88,445 | 2,242 |
| Other Operating Activity | 522,093 | 120,219 | 28,640 | 111,776 | 34,271 |
| Operating Cash Flow | $651,558 | $479,064 | $388,571 | $240,110 | $299,440 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 474,893 | -252,027 | -81,615 | 490,919 | -404,832 |
| PPE Investments | -6,970 | -10,696 | -15,294 | 21,196 | -1,457 |
| Net Acquisitions | -1,013,736 | N/A | N/A | -999,120 | N/A |
| Investing Cash Flow | $-545,813 | $-262,723 | $-96,909 | $-487,005 | $-406,289 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,470,000 | N/A | N/A | 1,072,000 | 784,875 |
| Debt Repayment | -1,229,693 | N/A | -13,483 | -516,573 | -369,064 |
| Common Stock Issued | 21,829 | 31,139 | 7,879 | 14,050 | 12,536 |
| Common Stock Repurchased | -342,372 | -250,000 | -402,383 | -200,002 | -350,058 |
| Other Financing Activity | -4,938 | 0 | 0 | -7,104 | -424 |
| Financing Cash Flow | $-85,174 | $-218,861 | $-407,987 | $362,371 | $77,865 |
| Beginning Cash Position | 115,850 | 118,370 | 234,695 | 119,219 | 148,203 |
| End Cash Position | 136,421 | 115,850 | 118,370 | 234,695 | 119,219 |
| Net Cash Flow | $20,571 | $-2,520 | $-116,325 | $115,476 | $-28,984 |
| Free Cash Flow | |||||
| Operating Cash Flow | 651,558 | 479,064 | 388,571 | 240,110 | 299,440 |
| Capital Expenditure | -6,970 | -10,696 | -15,294 | -4,810 | -1,457 |
| Free Cash Flow | 644,588 | 468,368 | 373,277 | 235,300 | 297,983 |